AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Galderma Laboratories withdrew one of its patient informational sheets from distribution after the Food and Drug Administration warned that the company's promotional materials minimized risks to pregnant women. In a letter to Galderma, FDA said that the patient information on Solage (mequinol 2%, tretinoin 0.01%) topical solution, a treatment for solar lentigines, was misleading ...